MXPA04012732A - Plataforma para formulaciones transdermicas (pft). - Google Patents
Plataforma para formulaciones transdermicas (pft).Info
- Publication number
- MXPA04012732A MXPA04012732A MXPA04012732A MXPA04012732A MXPA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A
- Authority
- MX
- Mexico
- Prior art keywords
- platform
- ptf
- transdermal formulations
- therapeutically active
- transdermal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 235000015097 nutrients Nutrition 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10228680A DE10228680A1 (de) | 2002-06-27 | 2002-06-27 | Grundlage für transdermale Formulierungen (PTF) |
| PCT/IB2003/003467 WO2004002444A2 (en) | 2002-06-27 | 2003-06-21 | A platform for transdermal formulations (ptf) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04012732A true MXPA04012732A (es) | 2005-11-17 |
Family
ID=29761469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04012732A MXPA04012732A (es) | 2002-06-27 | 2003-06-21 | Plataforma para formulaciones transdermicas (pft). |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050118241A1 (OSRAM) |
| EP (1) | EP1515706A2 (OSRAM) |
| JP (1) | JP2005535635A (OSRAM) |
| KR (1) | KR20050027995A (OSRAM) |
| CN (1) | CN1665492A (OSRAM) |
| AR (1) | AR040287A1 (OSRAM) |
| AU (1) | AU2003252459A1 (OSRAM) |
| CA (1) | CA2490022A1 (OSRAM) |
| DE (1) | DE10228680A1 (OSRAM) |
| MX (1) | MXPA04012732A (OSRAM) |
| MY (1) | MY157852A (OSRAM) |
| TW (1) | TW200500093A (OSRAM) |
| WO (1) | WO2004002444A2 (OSRAM) |
| ZA (1) | ZA200500710B (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033998B2 (en) * | 2003-04-11 | 2006-04-25 | All Natural Fmg, Inc. | Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
| WO2005094210A2 (en) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Multi-action anthelmintic formulations |
| US10042980B2 (en) | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
| US20110145009A1 (en) * | 2005-11-30 | 2011-06-16 | Jung Edward K Y | Methods and systems related to transmission of nutraceutical associatd information |
| US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
| WO2010132562A2 (en) * | 2009-05-12 | 2010-11-18 | Ohio University | Transdermal delivery of metformin |
| WO2010141956A2 (en) * | 2009-06-05 | 2010-12-09 | Caron Joan M | Methods and compositions for the treatment of cancer |
| ES2688397T3 (es) * | 2012-07-30 | 2018-11-02 | Matinas Biopharma Nanotechnologies, Inc. | Cocleatos hechos con fosfatidilserina de soja |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4878892A (en) * | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
| FR2616333A1 (fr) * | 1987-06-12 | 1988-12-16 | Cird | Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant |
| JPS63316737A (ja) * | 1987-06-19 | 1988-12-26 | Toyo Jozo Co Ltd | 経鼻投与用医薬組成物 |
| IT1223343B (it) * | 1987-11-03 | 1990-09-19 | Also Lab Sas | Formulazioni farmaceutiche per somministrazione transdermica |
| US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| EP0429842B1 (en) * | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
| US5073539A (en) * | 1990-01-22 | 1991-12-17 | Ciba-Geigy Corporation | Transdermal administration of zwitterionic drugs |
| ATE147620T1 (de) * | 1991-07-26 | 1997-02-15 | Smithkline Beecham Corp | W/o mikroemulsionen |
| FR2687321B1 (fr) * | 1992-02-14 | 1999-04-16 | Elf Aquitaine | Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet. |
| US5894021A (en) * | 1994-09-30 | 1999-04-13 | Kabushiki Kaisya Advance | Iontophoretic transdermal drug-delivery interface and skin treatment agent and treatment method using the same |
| US5707641A (en) * | 1994-10-13 | 1998-01-13 | Pharmaderm Research & Development Ltd. | Formulations comprising therapeutically-active proteins or polypeptides |
| US5759445A (en) * | 1995-05-24 | 1998-06-02 | Matsushita Electric Industrial Co., Ltd. | Lipid-dispersed solution and process for producing the same |
| US6183758B1 (en) * | 1998-01-29 | 2001-02-06 | Highland Laboratories, Inc. | Phytochemicals, nutrients & medication absorption &/or treatment |
| PT1094781E (pt) * | 1998-07-07 | 2008-10-08 | Transdermal Technologies Inc | Composições para administração transdérmica rápida e não irritante de agentes farmacologicamente activos e métodos para formulação de tais composições e sua administração |
| TR200103188T2 (tr) * | 1999-05-07 | 2002-04-22 | Pharmasol Gmbh | Sıvı ve katı lipit karışımları temelli lipid parçacıklar. |
| US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
-
2002
- 2002-06-27 DE DE10228680A patent/DE10228680A1/de not_active Withdrawn
-
2003
- 2003-06-21 AU AU2003252459A patent/AU2003252459A1/en not_active Abandoned
- 2003-06-21 KR KR1020047021277A patent/KR20050027995A/ko not_active Withdrawn
- 2003-06-21 JP JP2004517161A patent/JP2005535635A/ja active Pending
- 2003-06-21 CA CA002490022A patent/CA2490022A1/en not_active Abandoned
- 2003-06-21 US US10/511,463 patent/US20050118241A1/en not_active Abandoned
- 2003-06-21 MX MXPA04012732A patent/MXPA04012732A/es not_active Application Discontinuation
- 2003-06-21 CN CN038151030A patent/CN1665492A/zh active Pending
- 2003-06-21 EP EP03761748A patent/EP1515706A2/en not_active Withdrawn
- 2003-06-21 WO PCT/IB2003/003467 patent/WO2004002444A2/en not_active Ceased
- 2003-06-23 TW TW092116951A patent/TW200500093A/zh unknown
- 2003-06-24 MY MYPI20032357A patent/MY157852A/en unknown
- 2003-06-27 AR ARP030102324A patent/AR040287A1/es not_active Application Discontinuation
-
2005
- 2005-01-03 ZA ZA200500710A patent/ZA200500710B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050027995A (ko) | 2005-03-21 |
| WO2004002444A3 (en) | 2004-03-11 |
| DE10228680A1 (de) | 2004-01-22 |
| WO2004002444A2 (en) | 2004-01-08 |
| US20050118241A1 (en) | 2005-06-02 |
| JP2005535635A (ja) | 2005-11-24 |
| CN1665492A (zh) | 2005-09-07 |
| ZA200500710B (en) | 2005-09-05 |
| TW200500093A (en) | 2005-01-01 |
| EP1515706A2 (en) | 2005-03-23 |
| AU2003252459A1 (en) | 2004-01-19 |
| AR040287A1 (es) | 2005-03-23 |
| CA2490022A1 (en) | 2004-01-08 |
| MY157852A (en) | 2016-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY141815A (en) | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| AP1954A (en) | Controlled release compositions comprising nimesulide. | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| AU2274201A (en) | Compounds and compositions for delivering active agents | |
| TR200103493T2 (tr) | Metaloproteaz önleyicileri | |
| NZ524767A (en) | Composition for the transdermal delivery of fentanyl | |
| PT1412384E (pt) | Formulação estável de glp-1 modificado | |
| CY1108766T1 (el) | Συνθεσεις και μεθοδοι για την προληψη ή την μειωση της αντοχης των εντομων στα εντομοκτονα | |
| MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
| MXPA04004567A (es) | Compuestos y composiciones de fenoxi amina para adminstrar agentes activos. | |
| SE0102843D0 (sv) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
| AU2084801A (en) | Antiviral medication | |
| MXPA04012732A (es) | Plataforma para formulaciones transdermicas (pft). | |
| TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
| SE9800905D0 (sv) | New therapy in glomerulonephritis | |
| AU2002241270A1 (en) | Compositions for delivering biologically active drug and method of using the same | |
| AU2003235931A1 (en) | Vintoperol-containing medicinal composition for transdermal administration | |
| AU2002236587A1 (en) | Compositions for adhesion prevention | |
| AU6629000A (en) | Novel hypoxanthine and thiohypoxanthine compounds | |
| MXPA04006269A (es) | Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. | |
| WO2004056353A3 (en) | Device and method for delivering mmp inhibitors | |
| NZ521515A (en) | Composition comprising paracetamol and niflumic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |